Reference number : 236-2012-2013-Q4-00156, amendment number : , agreement type : G, recipient legal name : FANTUS, Ivan G, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 1X5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 382479.0, agreement start date : 2013-01-01, agreement end date : 2015-12-31, description english : Neutraceuticals and diabetes:  Nrf-2 activation is a critical mechanism underlying the effect of certain plant-derived compounds in preventing insulin resistance., description french : Neutraceuticals and diabetes:  Nrf-2 activation is a critical mechanism underlying the effect of certain plant-derived compounds in preventing insulin resistance., expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2012-13 to 2015-16), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2012-13 à 2015-16), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada